Form 8-K - Current report:
SEC Accession No. 0001193125-24-189569
Filing Date
2024-07-31
Accepted
2024-07-31 09:05:29
Documents
15
Period of Report
2024-07-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d858316d8k.htm   iXBRL 8-K 25297
2 EX-99.1 d858316dex991.htm EX-99.1 18526
6 GRAPHIC g858316g0731020058828.jpg GRAPHIC 3024
  Complete submission text file 0001193125-24-189569.txt   173575

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240731.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240731_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240731_pre.xml EX-101.PRE 10806
18 EXTRACTED XBRL INSTANCE DOCUMENT d858316d8k_htm.xml XML 3533
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 241160042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)